| Document Date: 2015-01-08 15:08:52
Open Document File Size: 233,52 KBShare Result on Facebook
City Reference / / Company Ames / LEO Pharma Inc. / / Event Product Recall / Product Issues / / IndustryTerm treatment site / corticosteroid combination product / corticosteroid-containing product / mineral oil / / MedicalCondition intracranial hypertension / Allergic Contact Dermatitis / Skin Irritation If irritation / scaly rash / Topical Calcipotriene Allergic contact dermatitis / very severe plaque psoriasis / Cushing's syndrome / Headache / liver failure / Plaque Psoriasis A / plaque psoriasis / Pruritis / benign C-cell adenomas / acneiform eruptions / secondary infection / miliaria / least moderate disease / skin hypopigmentation / mild disease / Psoriasis / pruritus / Influenza / exfoliative psoriasis / skin hyperpigmentation / respiratory tract infection / adrenal insufficiency / tumor / ________________WARNINGS AND PRECAUTIONS_______________ Hypercalcemia / telangiectasia / skin infection / umbilical hernia / disease / Nasopharyngitis / Topical Corticosteroids Allergic contact dermatitis / very mild disease / Carcinogenesis / hyperglycemia / Hypercalciuria Hypercalcemia / folliculitis / Skin Irritation / Erythema / erythrodermic psoriasis / controlled disease / cleft palate / perioral dermatitis / Hypercalcemia / extensive plaque psoriasis / exencephaly / skin tumors / pustular psoriasis / benign pheochromocytomas / irritation / moderate disease / hand dermatitis / calcium metabolism disorder / Rash / baseline disease / syndrome / / MedicalTreatment light therapy / phototherapy / radiation / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Position Investigator / physician / / Product vitamin D / cosyntropin / drug / TACLONEX / treatment / calcipotriene / betamethasone dipropionate / / ProgrammingLanguage C / / Technology alpha / radiation / Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov / /
SocialTag |
TACLONEX® (calcipotriene and betamethasone dipropionate)